Home > PJ (current issue) > News / Daily News | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7335 p135-139
5 February 2005

This section
Reprint   Photocopy

PDF 270K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

135 Co-proxamol withdrawal is widely welcomed Pharmacists have welcomed the decision by health safety regulators to withdraw the prescription painkiller co-proxamol. However, the Royal Pharmaceutical Society has criticised the way in which the withdrawal was communicated ...more

135 New guidance on out-of-hours medicines Access to medicines out of hours looks set to improve following the publication of new guidance by the Department of Health ...more

135 NPA advanced services course The National Pharmaceutical Association has produced a distance learning training course to prepare pharmacists to meet the competencies required to provide advanced services under the new community pharmacy contract ...more

136 First section of new Welsh health report published Health statistics about people living in Wales were published by the Welsh Assembly Government this week, in the first section of a new report ...more

136 Scottish sexual health strategy launched A new sexual health strategy has been published by the Scottish Executive ...more

136 Community pharmacy numbers stable for past 10 years The number of community pharmacies in England and Wales with NHS dispensing contracts has changed little over the past 10 years, having fallen from 10,486 in 1994–95 to 10,462 in 2003–04 ...more

136 Serious Fraud Office expands generics price-fixing inquiry The Serious Fraud Office this week confirmed its investigation into suspected price-fixing by generics manufacturers and suppliers has been expanded to include more companies ...more

136 MHRA gives evidence to pharmaceutical industry influence inquiry The Medicines and Healthcare products Regulatory Agency will, from the middle of the year, issue a “United Kingdom product public assessment report” for each licence it issues, Sir Alasdair Breckenridge, chairman of the board of the MHRA, said last week ...more

137 GMC review launched in wake of Shipman inquiry The role, structure and function of the General Medical Council, which regulates doctors in the UK, is to be reviewed, Secretary of State for Health John Reid has announced. The move follows criticism and recommendations by the chairman of the Shipman Inquiry, Dame Janet Smith, last year ...more

137 Final inquiry report suggests 250 patients were unlawfully killed by Harold Shipman Harold Shipman killed about 250 patients between 1971 and 1998, Dame Janet Smith, chairman of the Shipman Inquiry, concludes in her sixth and final report ...more

137 MP calls for warning symbols on medicines Labour member of Parliament Andrew Dismore (Hendon) has launched a 10-Minute Rule bill to establish a system of prominently displayed warning symbols on the packaging of medicines that can impair driving and mechanical ability ...more

137 MHRA starts review of ban on kava in unlicensed medicines The two-year-old ban on kava in unlicensed medicines is to be reviewed ...more

138 No magic pill for symptoms related to dementia There is convincing evidence to support use of the atypical antipsychotics risperidone (Risperdal) and olanzapine (Zyprexa) to treat the neuropsychiatric symptoms of dementia, according to US researchers. However, they say that no agent offers a “magic pill” against these symptoms ...more

138 Pregnancy complications not increased by inhaled corticosteroids in women with asthma Women with asthma who use inhaled corticosteroids while pregnant do not have an increased risk of pregnancy-induced hypertension or pre-eclampsia. Women with uncontrolled and severe asthma, however, may be at an increased risk of these conditions ...more

138 Consultation to revamp milk voucher scheme launched A consultation on an initiative to replace the current Welfare Food Scheme has been launched by the Department of Health ...more

138 Asthma characteristics predict response to treatment Researchers have identified characteristics in children with asthma that could help predict the type of treatment they will respond to ...more

139 Tonnes of inappropriate medicines arrive in SE Asia Tonnes of inappropriate medicines have arrived in South-East Asia following the tsunami disaster, according to a report by Pharmaciens Sans Frontières (PSF) ...more

139 Stop-smoking advice to be given to children in Scotland A Scottish scheme to provide a smoking cessation service through schools, youth centres and community venues to those aged 14–18 years will be launched in Lanarkshire later this year ...more

139 Childhood smoke exposure linked to adult lung cancer Frequent exposure to environmental tobacco smoke during childhood is associated with lung cancer in adulthood, a long-term, prospective study published on BMJ Online First has shown ...more

139 NHS should pay premium price for rare disease treatments The NHS should pay the premium price for drugs to treat patients with rare conditions, according to a public panel that advises the National Institute for Clinical Excellence ...more

139 NPfIT timescales announced Approximate timescales for implementation of some of the stages of the National Programme for IT (NPfIT) have been posted on the NPfIT website ...more

139 Pepto-Bismol reclassification Procter & Gamble has asked the Medicines and Healthcare products Regulatory Agency to reclassify Pepto-Bismol as a general sale list medicine ...more

139 Graham Phillips quits NPA board Graham Phillips has resigned from the National Pharmaceutical Association management board so that he can concentrate his efforts where he believes they are most needed ...more

Back to Top


©The Pharmaceutical Journal